Oman vs Serbia: Hepatitis B surface antigen (HBsAg) prevalence
Oman
0.1%
in 2024
Serbia
0.1%
in 2024
Oman rank
101st
Serbia rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Oman
- Serbia
How they compare
Oman currently reports 0.1% against 0.1% in Serbia, a difference of 0.0%.
Across all 10 years both countries report, Serbia has been ahead every year.
Oman ranks 101st and Serbia ranks 101st of 194 countries.
Serbia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Oman | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | Serbia |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Oman or Serbia?
- Oman, at 0.1% against 0.1% in Serbia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Oman and Serbia?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Serbia?
- 10 years are reported by both, from 2015 to 2024.
- How do Oman and Serbia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Oman ranks 101st and Serbia ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.